Similar Papers

Paper Title
Journal
Date
Author
Anti–Integrin αvβ6 Antibody as a Diagnostic Marker for Pediatric Patients With Ulcerative Colitis
Yuya Muramoto
Gastroenterology | VOL. 163
Yuya MuramotoYuya Muramoto
13 Jun 2022
New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease
L Amati ... V Covelli
Immunopharmacology and Immunotoxicology | VOL. 28
L Amati, et. al.L Amati ... V Covelli
01 Jan 2006
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis
Ivan Monteleone ... Francesco Pallone
Gastroenterology | VOL. 130
Ivan Monteleone, et. al.Ivan Monteleone ... Francesco Pallone
01 Feb 2006
Neither Hide Nor Hair: The Difficulty of Identifying Useful Disease Biomarkers
Alan Huett ... Ramnik J Xavier
Gastroenterology | VOL. 134
Alan Huett, et. al.Alan Huett ... Ramnik J Xavier
16 May 2008
View more papers

More From: Journal of Crohn's and Colitis

Paper Title
Journal
Date
Author
P0293 The utility of small bowel capsule endoscopy in Crohn’s Disease – a retrospective cohort study
J H Yeo ... I Parisi
Journal of Crohn's and Colitis | VOL. 19
J H Yeo, et. al.J H Yeo ... I Parisi
22 Jan 2025
P0755 Long-term safety of subcutaneous vedolizumab in Ulcerative Colitis and Crohn’s disease: Findings from the VISIBLE OLE study
S Vermeire ... G D’Haens
Journal of Crohn's and Colitis | VOL. 19
S Vermeire, et. al.S Vermeire ... G D’Haens
22 Jan 2025
P0195 Immune reconstitution following autologous hematopoietic stem cell transplantation with cyclophosphamide-free mobilization for refractory Crohn’s disease
E Saager ... H Fidder
Journal of Crohn's and Colitis | VOL. 19
E Saager, et. al.E Saager ... H Fidder
22 Jan 2025
P0586 Nationwide population-based cohort study on the use and persistence of infliximab (IV and SC) in France: the Riposte IBD study
J Kirchgesner ... C Prati
Journal of Crohn's and Colitis | VOL. 19
J Kirchgesner, et. al.J Kirchgesner ... C Prati
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.